S1P receptor from Central nervous system to clinical use
All times in GMT
Chair: Pr Roland Liblau (Toulouse, France)
12:45 – 13:00 Lymphocyte dynamics in the central nervous system during health and in Multiple Sclerosis
Pr. Britta Engelhardt (Bern, Switzerland)
13:00-13:15 Role of S1P receptors and CNS migration cells
Pr Jack Antel (Montreal, Canada)
13:15-13:30 Targeting and involvement of S1PR modulators in Multiple Sclerosis and other pathologies
Pr Jeffrey A Cohen (Cleveland, USA)
13:30-13:45 Questions and Conclusion
Pr Roland Liblau and all
